Articles:

Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications

F Ciardiello and G Tortora
Clin Cancer Res 1998 4: 821 [Abstract] [PDF]  

p53 and RB expression predict progression in T1 bladder cancer

HB Grossman, M Liebert, M Antelo, CP Dinney, SX Hu, JL Palmer, and WF Benedict
Clin Cancer Res 1998 4: 829 [Abstract] [PDF]  

Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer

LL Nielsen, P Lipari, J Dell, M Gurnani, and G Hajian
Clin Cancer Res 1998 4: 835 [Abstract] [PDF]  

Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast

KM Alle, SM Henshall, AS Field, and RL Sutherland
Clin Cancer Res 1998 4: 847 [Abstract] [PDF]  

Quantitative analysis of carcinoembryonic antigen messenger RNA in peripheral venous blood and portal blood of patients with pancreatic ductal adenocarcinoma

NO Funaki, J Tanaka, R Hosotani, M Kogire, H Suwa, and M Imamura
Clin Cancer Res 1998 4: 855 [Abstract] [PDF]  

Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow

D Seong, P Thall, HM Kantarjian, M Talpaz, J Swantkowski, J Xu, Y Shen, A Glassman, L Ramagli, and MJ Siciliano
Clin Cancer Res 1998 4: 861 [Abstract] [PDF]  

Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype

R Swiercz, JD Wolfe, A Zaher, and J Jankun
Clin Cancer Res 1998 4: 869 [Abstract] [PDF]  

Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes

A Paredes-Zaglul, JJ Kang, YP Essig, W Mao, R Irby, M Wloch, and TJ Yeatman
Clin Cancer Res 1998 4: 879 [Abstract] [PDF]  

An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies

RM Mohammad, A Al-Katib, GR Pettit, VK Vaitkevicius, U Joshi, V Adsay, AP Majumdar, and FH Sarkar
Clin Cancer Res 1998 4: 887 [Abstract] [PDF]  

Preclinical antitumor activity of an antibody against the leukocyte antigen CD48

H Sun, BJ Norris, K Atkinson, JC Biggs, and GM Smith
Clin Cancer Res 1998 4: 895 [Abstract] [PDF]  

Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells

FM Uckun, RK Narla, X Jun, T Zeren, T Venkatachalam, KG Waddick, A Rostostev, and DE Myers
Clin Cancer Res 1998 4: 901 [Abstract] [PDF]  

Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients

SE Shackney, AA Pollice, CA Smith, LE Janocko, L Sweeney, KA Brown, SG Singh, L Gu, R Yakulis, and JF Lucke
Clin Cancer Res 1998 4: 913 [Abstract] [PDF]  

Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer

NJ Vogelzang, S Mani, RL Schilsky, RH Ansari, D Taber, SN Rhinehart, JC Garcia, SC Meyer, R Mick, BE Brockstein, WM Stadler, MJ Ratain, and EE Vokes
Clin Cancer Res 1998 4: 929 [Abstract] [PDF]  

Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial

MT Bandealy, R Gonin, PJ Loehrer, F Monaco, and LH Einhorn
Clin Cancer Res 1998 4: 935 [Abstract] [PDF]  

Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients

B Reigner, J Verweij, L Dirix, J Cassidy, C Twelves, D Allman, E Weidekamm, B Roos, L Banken, M Utoh, and B Osterwalder
Clin Cancer Res 1998 4: 941 [Abstract] [PDF]  

Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism

GJ Hunter, LM Hamberg, N Choi, RK Jain, T McCloud, and AJ Fischman
Clin Cancer Res 1998 4: 949 [Abstract] [PDF]  

Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma

YJ Wen, M Ling, R Bailey-Wood, and SH Lim
Clin Cancer Res 1998 4: 957 [Abstract] [PDF]  

Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer

C Ricciardelli, K Mayne, PJ Sykes, WA Raymond, K McCaul, VR Marshall, and DJ Horsfall
Clin Cancer Res 1998 4: 963 [Abstract] [PDF]  

Loss of heterozygosity on chromosome 18q in cohesive-type gastric cancer is associated with tumor progression and poor prognosis

T Inoue, S Uchino, N Shiraishi, Y Adachi, and S Kitano
Clin Cancer Res 1998 4: 973 [Abstract] [PDF]  

Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes

Y Kobayashi, M Yoshinouchi, G Tianqi, K Nakamura, A Hongo, S Kamimura, Y Mizutani, J Kodama, Y Miyagi, and T Kudo
Clin Cancer Res 1998 4: 979 [Abstract] [PDF]  

Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts

R Giavazzi, A Garofalo, C Ferri, V Lucchini, EA Bone, S Chiari, PD Brown, MI Nicoletti, and G Taraboletti
Clin Cancer Res 1998 4: 985 [Abstract] [PDF]  

Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo

D Yang, CT Kuan, J Payne, A Kihara, A Murray, LM Wang, M Alimandi, JH Pierce, I Pastan, and ME Lippman
Clin Cancer Res 1998 4: 993 [Abstract] [PDF]  

Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2

LN Harris, L Yang, C Tang, D Yang, and R Lupu
Clin Cancer Res 1998 4: 1005 [Abstract] [PDF]  

Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts

N Sawada, T Ishikawa, Y Fukase, M Nishida, T Yoshikubo, and H Ishitsuka
Clin Cancer Res 1998 4: 1013 [Abstract] [PDF]  

Activity of oxaliplatin against human tumor colony-forming units

E Raymond, R Lawrence, E Izbicka, S Faivre, and DD Von Hoff
Clin Cancer Res 1998 4: 1021 [Abstract] [PDF]  

Impairment of the actin-myosin interaction in permeabilized cardiac trabeculae after chronic doxorubicin treatment

AE Bottone, EE Voest, and EL de Beer
Clin Cancer Res 1998 4: 1031 [Abstract] [PDF]  

Interleukin 6 differentially potentiates the antitumor effects of taxol and vinblastine in U266 human myeloma cells

M Aoyama, D MacIsaac, RM Bukowski, and MK Ganapathi
Clin Cancer Res 1998 4: 1039 [Abstract] [PDF]  

Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment

S Fan, B Cherney, W Reinhold, K Rucker, and PM O'Connor
Clin Cancer Res 1998 4: 1047 [Abstract] [PDF]  

Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins

X Zi, DK Feyes, and R Agarwal
Clin Cancer Res 1998 4: 1055 [Abstract] [PDF]  

Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma

J Yao, RE Pollock, A Lang, M Tan, PW Pisters, D Goodrich, A El-Naggar, and D Yu
Clin Cancer Res 1998 4: 1065 [Abstract] [PDF]  

The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium

H Ouyang, T Furukawa, T Abe, Y Kato, and A Horii
Clin Cancer Res 1998 4: 1071 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.